LeMaitre Vascular yesterday posted fourth-quarter results that beat the consensus forecast on Wall Street.

The Burlington, Mass.-based company report profits of $7 million, or 34¢ per share, on sales of $37.5 million for the three months ended Dec. 31, 2020, for a bottom-line gain of 52.5% on sales growth of 24.5% compared with Q4 2019.

Earnings per share were 34¢, 5¢ ahead of The Street where analysts were looking for sales of $35.6 million.

“For Q4, record sales combined with expense control to produce healthy bottom-line results and an improved balance sheet. For 2020 we reported 10% sales growth and 36% op. income growth. 2021 marks a decade of yearly dividend growth at LeMaitre,” CEO George LeMaitre said in a news release.

LeMaitre Vascular did not provide a financial outlook for 2021.

Shares in LMAT were up 10.7% to $51.42 apiece in afternoon trading.